# Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia

> **NCT07154485** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hee-Jin Kim** · enrollment: 15 (estimated)

## Conditions studied

- Dementia Frontotemporal

## Interventions

- **DRUG:** NS101 IV infusion
- **DRUG:** Placebo IV Infusion

## Key facts

- **NCT ID:** NCT07154485
- **Lead sponsor:** Hee-Jin Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154485, "Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07154485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*